Consultant Haematology Lead

Job Requisition ID: 3516
- Legal Entity: Monash Health
- Location: Bentleigh East, VIC, AU, 3165
- Employment Type: Part Time
- Posting Date: 29 Jan 2025

**Monash Health is a great place to work**

To learn more about our organisation visit **monashhealth.org**.

To see first-hand what our colleagues think about working here, take a look at the following short videos**:monashhealth.org/careers**.

Monash Health is Victoria’s largest and most comprehensive health service. For more than 170 years, Monash Health and its predecessors have provided safe, high-quality healthcare for people at every life stage. With 25,500 employees, we provide care to south-eastern metropolitan Melbourne and rural Victoria from over 40 locations, via telehealth, within local communities and in people’s homes.

We recognise the value of equal employment opportunity. We are committed to patient safety, promoting fairness, equity and diversity in the workplace and to Child Safe Standards. At Monash Health we are relentless in our pursuit of excellence and work to our six guiding principles and our five ICare values.

**About Monash Doctors**

To help grow your career, there are more than 1,900 Junior and 1,700 Senior Doctors at Monash Health in over 200 medical specialties. We offer unparallel opportunities in Victoria's largest & most clinically diverse teaching health service.

**About Monash Haematology**

Monash Haematology is a clinical and academic-focused department whose mission is to improve the health and well-being of patients with blood diseases by providing the best care to every patient through integrated clinical practice, education and research.
We provide haematology care to a population of approximately 1.3 million, making ours one of the largest services in Australia. Key clinical care and research areas include: Lymphoma and CLL, acute leukaemia and myelodysplastic syndromes, multiple myeloma, myeloproliferative disorders, venous thromboembolic disease and haemostatic disorders, haemoglobinopathies and transfusion medicine. Our clinical program is supported by an established Cell Therapy Program, including autologous stem cell transplant and chimeric antigen receptor T (CART)-cell capabilities within the Monash Health Translation Precinct and in partnership with the Hudson Institute Cell Therapy Platform.

Our department is actively engaged with research organisations including the School of Clinical Sciences, Monash University; the Centre for Cancer Research (CCR) at the Hudson Institute of Medical Research; the Australasian Leukaemia and Lymphoma Group (ALLG), and the Children’s Oncology Group (COG). In conjunction with Monash University, basic and translational science research groups are embedded within the state-of-the-art Monash Health Translational Precinct facility. Consistent with its strong academic ties to Monash University, the unit holds teaching and research as key metrics. There is a strong focus on evidence-based practise with clinical research integrated into all aspects of patient care.

**A Career Defining role leading the Monash High-Grade Lymphoma Program**

The lymphoma portfolio at Monash is one of our flagship programs, built upon a foundation of quality and excellence in lymphoma care embedded within an academic centre that leverages a state-of-art clinical trial facility within a large primary patient catchment. Monash Health frequently leads national and international recruitment in lymphoma studies and plays a key role in collaborative research ventures including ALLG studies and the ANZ Lymphoma & Related Diseases Registry. The primary focus of this role is to lead Monash Health’s Aggressive Lymphoma Program, including development and oversight of treatment protocols and the quality and consistency of care through multidisciplinary team meetings. The pursuit of clinical research strategies is a key priority, and the successful applicant will be highly engaged with clinical trials, including the strategic selection of clinical trial protocols at our site. The opportunity to represent Monash Health Haematology as a Principal Investigator on industry-sponsored and collaborative group trials will furnish a suite of academic outputs (e.g., publications, conference presentations) and access to international networks. It is important that the Monash Health Aggressive Lymphoma lead establishes themselves as a key opinion leader in the field and engages strongly with both industry and academic partners to access the best therapeutic options for our patients. The opportunity to undertake investigator-initiated research will be supported and encouraged. An understanding of haematologic disease particularly aggressive lymphoma biology, investigation, treatment and clinical trials is essential. The incumbent must contribute to regular functioning of the Haematology unit. There will also be a requirement to participate in the advanced trainee teaching program and other relevant unit and hospital e